Ardais Takes in $14M Series C

Ardais of Lexington, Mass., closed a $14 million Series C round of venture capital financing in December. The five-year-old firm, which serves as a repository for human tissue for research, took its last round of financing in March 2001 and was valued at $72 million then. Investors in the current round include CIT Group, Pequot Capital, Advanced Technology Ventures, Advent International, Bessemer Venture Partners, and The Kaufmann Fund.

 

Pioneer Hi-Bred Links With Agilent

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.